Tysabri Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Condition:   Multiple Sclerosis Interventions:   Drug: Diroximel Fumarate;   Biological: Alemtuzumab;   Drug: Fingolimod;   Drug: Glatiramer acetate;   Biological: Interferon beta;   Biological: Natalizumab;   Biological: Ocrelizumab;   Biological: Peginterferon beta-1a;   Drug: Siponimod Sponsor:   Biogen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials